Experimental: Baofukang Suppository 7 days
Phase 3Small molecule
Experimental: Baofukang Suppository 7 days is one of 9 small molecule programs targeting Vaginitis. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
14 competitors in Vaginitis
#DrugCompanyPhaseTrials
1Diflucan
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Lotrimin
BayerPhase 3
Chronulac
SSolvay Pharmaceuticals
Phase 3
Trolamine (biafine)
WWest China Hospital
Approved
Canesten
AAVVA Pharmaceuticals Ltd.
Phase 3
POLYGYNAX
LLaboratoire Innotech International
Phase 3
Experimental: Baofukang Suppository 7 days
PPeking University Shenzhen Hospital
Phase 3
Albaconazole
GSKPhase 2
TOL-463
TToltec Pharmaceuticals, LLC
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details